175 related articles for article (PubMed ID: 36840972)
41. Delta-like homologue 1 and its role in the bone marrow niche and hematologic malignancies.
Benetatos L; Hatzimichael E
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):451-5. PubMed ID: 25066037
[TBL] [Abstract][Full Text] [Related]
42. CD8
Monteiro AC; Bonomo A
Bone; 2021 Sep; 150():116014. PubMed ID: 34022456
[TBL] [Abstract][Full Text] [Related]
43. HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo.
Ikezoe T; Hisatake Y; Takeuchi T; Ohtsuki Y; Yang Y; Said JW; Taguchi H; Koeffler HP
Cancer Res; 2004 Oct; 64(20):7426-31. PubMed ID: 15492266
[TBL] [Abstract][Full Text] [Related]
44. Bone marrow/bone pre-metastatic niche for breast cancer cells colonization: The role of mesenchymal stromal cells.
Sanmartin MC; Borzone FR; Giorello MB; Pacienza N; Yannarelli G; Chasseing NA
Crit Rev Oncol Hematol; 2021 Aug; 164():103416. PubMed ID: 34237436
[TBL] [Abstract][Full Text] [Related]
45. P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment.
Azab AK; Quang P; Azab F; Pitsillides C; Thompson B; Chonghaile T; Patton JT; Maiso P; Monrose V; Sacco A; Ngo HT; Flores LM; Lin CP; Magnani JL; Kung AL; Letai A; Carrasco R; Roccaro AM; Ghobrial IM
Blood; 2012 Feb; 119(6):1468-78. PubMed ID: 22096244
[TBL] [Abstract][Full Text] [Related]
46. Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.
Jacamo R; Chen Y; Wang Z; Ma W; Zhang M; Spaeth EL; Wang Y; Battula VL; Mak PY; Schallmoser K; Ruvolo P; Schober WD; Shpall EJ; Nguyen MH; Strunk D; Bueso-Ramos CE; Konoplev S; Davis RE; Konopleva M; Andreeff M
Blood; 2014 Apr; 123(17):2691-702. PubMed ID: 24599548
[TBL] [Abstract][Full Text] [Related]
47. Disseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone.
Marsden CG; Wright MJ; Carrier L; Moroz K; Rowan BG
PLoS One; 2012; 7(11):e47587. PubMed ID: 23173031
[TBL] [Abstract][Full Text] [Related]
48. Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer.
Lu H; Chen CS; Waxman DJ
Cancer Gene Ther; 2009 May; 16(5):393-404. PubMed ID: 19011599
[TBL] [Abstract][Full Text] [Related]
49. The bone marrow microenvironment as a sanctuary for minimal residual disease in CML.
Nair RR; Tolentino J; Hazlehurst LA
Biochem Pharmacol; 2010 Sep; 80(5):602-12. PubMed ID: 20382130
[TBL] [Abstract][Full Text] [Related]
50. Remodelling of the bone marrow microenvironment by stromal hyaluronan modulates the malignancy of breast cancer cells.
Chen X; Shi X; Liu Y; He Y; Du Y; Zhang G; Yang C; Gao F
Cell Commun Signal; 2020 Jun; 18(1):89. PubMed ID: 32517712
[TBL] [Abstract][Full Text] [Related]
51. TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment.
Tabe Y; Shi YX; Zeng Z; Jin L; Shikami M; Hatanaka Y; Miida T; Hsu FJ; Andreeff M; Konopleva M
PLoS One; 2013; 8(6):e62785. PubMed ID: 23826077
[TBL] [Abstract][Full Text] [Related]
52. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment.
Frolova O; Samudio I; Benito JM; Jacamo R; Kornblau SM; Markovic A; Schober W; Lu H; Qiu YH; Buglio D; McQueen T; Pierce S; Shpall E; Konoplev S; Thomas D; Kantarjian H; Lock R; Andreeff M; Konopleva M
Cancer Biol Ther; 2012 Aug; 13(10):858-70. PubMed ID: 22785211
[TBL] [Abstract][Full Text] [Related]
53. Blockade of VLA4 sensitizes leukemic and myeloma tumor cells to CD3 redirection in the bone marrow microenvironment.
Nair-Gupta P; Rudnick SI; Luistro L; Smith M; McDaid R; Li Y; Pillarisetti K; Joseph J; Heidrich B; Packman K; Attar R; Gaudet F
Blood Cancer J; 2020 Jun; 10(6):65. PubMed ID: 32483120
[TBL] [Abstract][Full Text] [Related]
54. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
55. CXCR4 expression in the bone marrow microenvironment is required for hematopoietic stem and progenitor cell maintenance and early hematopoietic regeneration after myeloablation.
Singh P; Mohammad KS; Pelus LM
Stem Cells; 2020 Jul; 38(7):849-859. PubMed ID: 32159901
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1α.
Mognetti B; La Montagna G; Perrelli MG; Pagliaro P; Penna C
J Cell Mol Med; 2013 Feb; 17(2):287-92. PubMed ID: 23301946
[TBL] [Abstract][Full Text] [Related]
57. Human Sinusoidal Subendothelial Cells Regulate Homing and Invasion of Circulating Metastatic Prostate Cancer Cells to Bone Marrow.
Funari A; Alimandi M; Pierelli L; Pino V; Gentileschi S; Sacchetti B
Cancers (Basel); 2019 May; 11(6):. PubMed ID: 31159336
[No Abstract] [Full Text] [Related]
58. Bone metastasis and the metastatic niche.
Ren G; Esposito M; Kang Y
J Mol Med (Berl); 2015 Nov; 93(11):1203-12. PubMed ID: 26275789
[TBL] [Abstract][Full Text] [Related]
59. Phenotypic alteration of bone marrow HSC and microenvironmental association in experimentally induced leukemia.
Basak P; Chatterjee S; Das M; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
Curr Stem Cell Res Ther; 2010 Dec; 5(4):379-86. PubMed ID: 20528754
[TBL] [Abstract][Full Text] [Related]
60. Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma.
Wang J; Faict S; Maes K; De Bruyne E; Van Valckenborgh E; Schots R; Vanderkerken K; Menu E
Oncotarget; 2016 Jun; 7(25):38927-38945. PubMed ID: 26950273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
